Thu, January 9, 2014
Wed, January 8, 2014
Tue, January 7, 2014
Mon, January 6, 2014
Sun, January 5, 2014
Fri, January 3, 2014
Thu, January 2, 2014
Tue, December 31, 2013
Fri, December 27, 2013
Tue, December 24, 2013
Mon, December 23, 2013
Fri, December 20, 2013
Thu, December 19, 2013
Wed, December 18, 2013

Joel Beatty Downgraded (SRPT) to Strong Sell and Held Target at $13 on, Jan 6th, 2014

Joel Beatty of Citigroup, Downgraded "Sarepta Therapeutics, Inc." (SRPT) to Strong Sell and Held Target at $13 on, Jan 6th, 2014.

Joel has made no other calls on SRPT in the last 4 months.



There are 2 other peers that have a rating on SRPT. Out of the 2 peers that are also analyzing SRPT, 1 agrees with Joel's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Joseph Schwartz of "Leerink Swann" Maintained at Hold with Decreased Target to $17 on, Tuesday, November 12th, 2013


This is the rating of the analyst that currently disagrees with Joel


  • Yun Zhong of "Janney Montgomery Scott" Downgraded from Hold to Strong Sell and Decreased Target to $10 on, Tuesday, November 12th, 2013